Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pheochromocytoma × Cyclophosphamide × Clear all

Sponsor

Conditions

Breast Neoplasms 138 Lymphoma 137 Precursor Cell Lymphoblastic Leukemia-Lymphoma 113 Lymphoma, Non-Hodgkin 107 Leukemia 106 Leukemia, Lymphocytic, Chronic, B-Cell 102 Multiple Myeloma 100 Lymphoma, Large B-Cell, Diffuse 86 Leukemia, Myeloid, Acute 83 Hodgkin Disease 72 Myelodysplastic Syndromes 70 Lymphoma, Follicular 67 Lymphoma, Mantle-Cell 66 Burkitt Lymphoma 59 Lymphoma, B-Cell, Marginal Zone 47 Melanoma 44 Neoplasms 40 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39 Recurrence 32 Lymphoma, Large-Cell, Immunoblastic 31 Hematologic Neoplasms 31 Neoplasms, Plasma Cell 28 Leukemia, Myelomonocytic, Chronic 27 Myeloproliferative Disorders 26 Primary Myelofibrosis 24 Lymphoma, Large-Cell, Anaplastic 24 Lymphoma, B-Cell 24 Congenital Abnormalities 24 Leukemia, Myeloid, Chronic-Phase 23 Leukemia, Myeloid, Accelerated Phase 23

Interventions

3-Iodobenzylguanidine 3 tipifarnib 1 pazopanib 1 lutetium Lu 177 dotatate 1 lenvatinib 1 guadecitabine 1 fostamatinib 1 copper dotatate CU-64 1 cabozantinib 1 atezolizumab 1 Temozolomide 1 Surgical Procedures, Operative 1 Phenoxybenzamine 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Iodine-131 1 Doxazosin 1 Capecitabine 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡